Dynavax Announces Proposed Public Offering of Common Stock
BERKELEY, CA, May 08, 2012 (MARKETWIRE via COMTEX) -- Dynavax Technologies
Corporation (DVAX) today announced that it intends to offer and sell shares of
its common stock, subject to market and other conditions, in an underwritten
public offering. Dynavax also expects to grant the underwriters a 30-day option
to purchase additional shares of its common stock to cover over-allotments, if
any. All of the shares in the offering are being offered by Dynavax.
J.P. Morgan Securities LLC is acting as sole book-running manager for the
offering. Cowen and Company, LLC is acting as co-manager.
The securities described above are being offered by Dynavax pursuant to two shelf
registration statements previously filed with and declared effective by the
Securities and Exchange Commission (the "SEC"). Preliminary prospectus
supplements related to the offering will be filed with the SEC and will be
available on the SEC's website located at sec.gov. Copies of the
preliminary prospectus supplements and the accompanying prospectuses relating to
this offering, when available, may be obtained from J.P. Morgan Securities LLC,
c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York
11717, or by telephone at 1-866-803-9204. |
